Promoter group acquires shares via warrant conversion

Promoter Stake BuyOwnership Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.7%Reaction day

₹67.45

prior close

₹68.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.0%+5.7% vs market

Healthcare Services peers, median of 58sector · industry level-0.9%+5.6% vs sector

On the reaction day the stock moved 5.7 pts more than Nifty Microcap 250 and 5.6 pts more than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

-0.0

15m

-0.0

30m

-0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.7-1.0+5.7-0.9+5.6

Next day

+5.3-0.4+5.6-0.3+5.6

-1.4-0.8-0.6-0.5-0.9

-0.7-1.9+1.2-1.5+0.8

-1.5-1.3-0.2-1.6+0.0

+3.4-1.0+4.4-1.3+4.6

+1.1-2.8+3.9-2.3+3.4

15d

+5.0+0.4+4.6-1.0+6.0

+14.0+2.4+11.6-1.2+15.2

+18.6+1.0+17.6-0.4+19.0

-2.9+1.8-4.6-8.9+6.0

UpDownMarket · Nifty Microcap 250Sector · Healthcare Services peers, median of 58Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Promoter group entity Srinidhi Fine Chemicals LLP acquired equity shares of Novelix Pharmaceuticals through conversion of warrants issued under a preferential allotment. The disclosure was filed under SEBI insider trading regulations, with the whole-time director Venkateshwarlu submitting it to BSE.

Likely market impact

Promoter buying signals confidence in the company. Likely increases promoter shareholding and reduces dilution overhang from warrants.